Prasugrel Hydrochloride 10 Mg Tablet

Prasugrel 10mg tablet is a medication primarily used for the prevention of blood clots in patients with acute coronary syndrome (ACS), specifically those undergoing percutaneous coronary intervention (PCI) procedures, such as angioplasty or stent placement. Prasugrel 10mg tablet is particularly beneficial for patients undergoing PCI procedures, where stents are placed in narrowed or blocked coronary arteries to restore blood flow to the heart muscle.

This medicine should come with a Medication Guide. Read and follow these instructions carefully. Ask your doctor or pharmacist if you have any questions. You may take this medicine with or without food.

Store at room temperature away from moisture and heat.

Blurred vision; dizziness; headache; nervousness; pounding in the ears; slow or fast heartbeat.

Evidence has demonstrated fetal abnormalities or risks when used during pregnancy.

Check with your doctor right away if you have the following symptoms: change in mental status, dark or bloody urine, difficulty with speaking, fever, pale color of the skin, pinpoint red spots on the skin, seizures, weakness, yellow eyes or skin. These may be symptoms of a serious condition called thrombotic thrombocytopenic purpura (TTP). This medicine may cause serious allergic reactions, including angioedema. Tell your doctor right away if you have chest pain, a rash, itching, swelling of the face, lips, tongue, or throat, or trouble with swallowing or breathing while you are using the medicine. Do not stop taking this medicine without checking with your doctor first. To do so may increase your risk for clots. Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal or vitamin supplements.

Product Information: EFFIENT(TM) oral tablets, prasugrel oral tablets. Eli Lilly, Indianapolis, IN, 2009. Prasugrel Stadafarma oral tablet, prasugrel hydrochloride oral tablet. Laboratorio Stada, SL (per AEMPS;Spain), Frederic Mompou, 5, 08960 Barcelona, Spain, 2019. Farid NA, Payne CD, Small DS, et al: Cytochrome P450 3A inhibition by ketoconazole affects prasugrel and clopidogrel pharmacokinetics and pharmacodynamics differently. Clin Pharmacol Ther 2007; 81(5):735-741.

Prasugrel is a thienopyridine which inhibits platelet activation and aggregation via irreversible inhibition of the platelet P2Y12 adenosine diphosphate (ADP) receptor [14][16][17]. Prasugrel is a prodrug and is rapidly metabolized to a pharmacologically active compound.

Platelet Aggregation Inhibitor